Skip to main content

Aims and scope

Thyroid Research is an online journal that aims to present the newest knowledge related to thyroid hormones, thyroid diseases and any related fields. The journal’s regular readership includes researchers, clinicians and healthcare providers across the world.

Thyroid Research encompasses a wide range of thyroidology topics including, diagnosis, pharmacological and other treatment methods, invasive treatment, physiological mechanisms of thyroid hormone action and regulation, immunological aspects, genetics, new guidelines in disease management, thyroid related diseases and complications.

The thyroid in pregnancy and infertility - challenges, diagnostics, and treatment

Guest Editor:

Sofie Bliddal: Copenhagen University Hospital, Denmark

Submission Status: Open until 31 December 2023


Featured article: Hypothyroidism in hibernating brown bears

Brown bears hibernate throughout half of the year as a survival strategy to reduce energy consumption during prolonged periods with scarcity of food and water. This report determines regulations in serum thyroid hormone levels in hibernation compared to the active state to investigate if these are involved in the adaptions for hibernation.

Thyroid Research’s 15th anniversary

Join our 15th anniversary celebration by discovering Thyroid Research’s collection of most influential articles. We would like to thank everyone who helped to achieve the goals of Thyroid Research.

Prof Bijay Vaidya

Bijay Vaidya is Consultant Endocrinologist at the Royal Devon & Exeter Hospital, and Honorary Clinical Professor at the University of Exeter Medical School, United Kingdom. He obtained his MBBS degree from the Darbhanga Medical College, Darbhanga, India and a PhD from the University of Newcastle upon Tyne, United Kingdom. He has clinical and research interest in thyroid diseases, particularly thyroid disorders in pregnancy. He has served as Treasurer and an Executive Committee Member of the British Thyroid Association, and is a member of the Clinical Committeee of the UK Society for Endocrinology and the Thyroid Eye Disease Amsterdam Declaration Implementation Group UK (TEAMeD UK). He has served on the ETA Guidelines Task Forces for ‘Non-autoimmune hyperthyroidism due to TSHR mutations’ and ‘Subclinical hypothyroidism in pregnant women and children’ and the Royal College of Physicians Guidelines Task Force for ‘Management of Thyroid Eye Disease’. Prof Vaidya has co-authored over 100 papers in peer-reviewed journals. 

Simone de LeoSimone de Leo

Simone de Leo graduated in Medicine and completed his fellowship in Endocrinology and Metabolic Diseases at the University of Milan under the guidance of Prof Luca Persani and Laura Fugazzola. During 2015 and 2016, he spent 18 months at Boston University where he worked as a research fellow supervised by Dr Lewis Braverman and Elizabeth Pearce and he was involved in studies about iodine deficiency, Graves’ disease, and thyroid disease in pregnancy. Currently he works as an Endocrinologist at the Istituto Auxologico Italiano of Milan and his research is focused on thyroid cancer. He published epidemiological, clinical, and molecular studies on this topic and he was an investigator in several clinical trials of TKIs, such as Lenvatinib, Vandetanib, Cabozantinib, and Selpercatinib. Since September 2018, he is a member of the Executive Committee and of the Website and Social Media Board of the European Thyroid Association. He participated and was invited to several national and international meetings, and won a poster contest at the Associazione Italiana della Tiroide meeting in 2012, the 15th International Thyroid Congress Trainee Grant Program in 2015, and the Presidential Poster Competition at the Endocrine Society in 2016.

Annual Journal Metrics

  • 2022 Citation Impact
    2.2 - 2-year Impact Factor
    2.2 - 5-year Impact Factor
    0.872 - SNIP (Source Normalized Impact per Paper)
    0.532 - SJR (SCImago Journal Rank)

    2022 Speed
    6 days submission to first editorial decision for all manuscripts (Median)
    107 days submission to accept (Median)

    2022 Usage 
    394 Altmetric mentions